BR100 Increased By (0.74%)
BR30 Increased By (0.78%)
KSE100 Increased By (0.77%)
KSE30 Increased By (0.84%)
AGHA 6.37 Decreased By ▼ -0.01 (-0.16%)
BECO 4.36 Increased By ▲ 0.01 (0.23%)
BML 63.09 Increased By ▲ 0.54 (0.86%)
BOP 31.42 Increased By ▲ 0.03 (0.1%)
CNERGY 11.78 Increased By ▲ 0.05 (0.43%)
CSIL 5.78 Decreased By ▼ -0.13 (-2.2%)
FCCL 61.70 Decreased By ▼ -0.01 (-0.02%)
FFL 14.83 Increased By ▲ 0.04 (0.27%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.33 Increased By ▲ 0.01 (0.16%)
KOSM 5.80 Decreased By ▼ -0.10 (-1.69%)
LOTCHEM 24.80 Increased By ▲ 0.11 (0.45%)
MLCF 105.60 Increased By ▲ 1.67 (1.61%)
NBP 174.56 Increased By ▲ 1.24 (0.72%)
NCPL 52.55 Increased By ▲ 0.72 (1.39%)
NPL 54.95 Increased By ▲ 0.92 (1.7%)
OGDC 318.47 Increased By ▲ 2.60 (0.82%)
PACE 9.25 Decreased By ▼ -0.01 (-0.11%)
PAEL 35.82 Increased By ▲ 0.24 (0.67%)
PIBTL 14.18 Increased By ▲ 0.52 (3.81%)
PPL 229.10 Increased By ▲ 3.03 (1.34%)
PRL 81.22 Increased By ▲ 0.94 (1.17%)
PTC 46.98 Increased By ▲ 0.34 (0.73%)
SSGC 23.82 No Change ▼ 0.00 (0%)
TBL 9.30 Increased By ▲ 0.06 (0.65%)
TELE 7.52 Decreased By ▼ -0.03 (-0.4%)
TPL 24.82 Increased By ▲ 0.28 (1.14%)
TPLP 12.99 No Change ▼ 0.00 (0%)
TREET 27.22 Increased By ▲ 1.24 (4.77%)
TRG 54.00 Increased By ▲ 0.67 (1.26%)
Technology

Lab-grown blood vessels built from patient’s cells to make dialysis easier

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers a
Published Updated

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers are trying to change by growing human blood vessels in lab by the patient’s cells in order to make dialysis easier.

Researchers from Humacyte Inc., Duke University and Yale have created lab-grown human blood vessels from the patient’s own cells, which will replace synthetic polymers and donor tissues that carry risks of inflammation and immune system rejection.

The process of dialysis, as per Engadget, mimics some few of the kidney’s main functions, but it requires a machine that pulls out blood from a blood vessel, filters it and pumps it back into the body. An extra blood vessel, either synthetic or donated, is implanted into the patient’s arm that channels blood into the dialysis machine.

Newly created urea sorbent paves way for wearable artificial kidneys

In contrast to usual dialysis, the new method, which is already heading into clinical trials, would allow the patient’s own cells to create the extra blood vessel to be implanted in the arm.

The researchers lined a biodegradable polymer tube with vascular cells from a deceased donor. For eight weeks, the cells multiplied and formed a new tube while the polymer scaffolding broke down. The team then took the cellular tube and implanted it to the patient’s arm. The patients’ cells migrated into the tubes and multiplied to create mature blood vessels.

Out of 60 patients that participated, 13 showed that blood vessels developed into multi-layered tissues that self-healed after injury, effectively becoming like the person’s own blood vessels, reported New Scientist.

Moreover, these bioengineered vessels also showed no signs of scarring or inflammatory reactions. The researchers further hope to create large numbers of engineered blood vessels that doctors can essentially obtain ‘off-the-shelf’ for using in patients with various vascular diseases, including heart disease.

Copyright Business Recorder, 2019

Comments

Comments are closed for this article.